SNY
$44.60-0.74 (-1.63%)
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions.
Recent News
Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6?
Organon & Co. develops branded and biosimilar therapies with a focus on women’s health and specialty pharmaceuticals.
Earendil Labs, an AI-powered drugmaker, hauls in $787M
The hefty funding will support a U.S. and China-based startup that’s amassed a pipeline of nearly 20 drugs and formed two lucrative partnerships with Sanofi.
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading
European equities traded in the US as American depositary receipts were down sharply late Thursday m
Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?
ALNY's strong drug sales and advancing pipeline, including late-stage candidates, are driving momentum and supporting its long-term growth outlook.
20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style
After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on dividend stock investing. My tenure at these premier Wall Street firms exposed me to fundamental analysis, credit evaluation, and risk management practices that directly translate into selecting high-quality dividend-paying companies. Having witnessed firsthand the 2008 ... 20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style